Arctic Launches Phase IIa Trial of AT-004 in Acne Vulgaris
11 Feb 2026 //
PR NEWSWIRE
Arctic Therapeutics Gets EMA Nod For AT-001 Phase 2a Study
03 Nov 2025 //
PR NEWSWIRE
Arctic Therapeutics research shows prevention strategy for HCCAA
02 Apr 2025 //
PR NEWSWIRE

Market Place
Sourcing Support